NO20065725L - En antimycobakteriell farmasoytisk sammensetning. - Google Patents

En antimycobakteriell farmasoytisk sammensetning.

Info

Publication number: NO20065725L
Authority: NO; Norway
Prior art keywords: pharmaceutical composition; antimycobacterial; methyl; antimycobacterial pharmaceutical; composition
Prior art date: 2004-05-12

Application number

NO20065725A

Other languages

English (en)

Norwegian (no)

Inventor

Neelima Sinha

Ram Shankar Upadhayaya

Sundershan Kumar Arora

Rakesh Kumar Sinha

Original Assignee

Lupin Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2006-12-12

Publication date

2006-12-12

2006-12-12 Application filed by Lupin Ltd filed Critical Lupin Ltd

2006-12-12 Publication of NO20065725L publication Critical patent/NO20065725L/no

Links

230000001355 anti-mycobacterial effect Effects 0.000 title abstract 2
239000003926 antimycobacterial agent Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
229940124976 antitubercular drug Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
PRXZOPNJRFEGRH-UHFFFAOYSA-N n-[2-methyl-5-phenyl-3-[[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]methyl]pyrrol-1-yl]pyridine-4-carboxamide Chemical compound C1=C(C=2C=CC=CC=2)N(NC(=O)C=2C=CN=CC=2)C(C)=C1CN(CC1)CCN1C1=CC=CC(C(F)(F)F)=C1 PRXZOPNJRFEGRH-UHFFFAOYSA-N 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
201000008827 tuberculosis Diseases 0.000 abstract 1
239000000814 tuberculostatic agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20065725A 2004-05-12 2006-12-12 En antimycobakteriell farmasoytisk sammensetning. NO20065725L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10/844,992 US7491721B2 (en)	2004-05-12	2004-05-12	Antimycobacterial pharmaceutical composition
PCT/IN2004/000266 WO2005107809A2 (en)	2004-05-12	2004-08-27	Antimycobacterial pharmaceutical composition comprising an antitubercular drug

Publications (1)

Publication Number	Publication Date
NO20065725L true NO20065725L (no)	2006-12-12

Family

ID=34960626

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065725A NO20065725L (no)	2004-05-12	2006-12-12	En antimycobakteriell farmasoytisk sammensetning.

Country Status (44)

Country	Link
US (1)	US7491721B2 (de)
EP (1)	EP1750765B1 (de)
JP (1)	JP2007537242A (de)
KR (1)	KR100854309B1 (de)
CN (1)	CN1956732B (de)
AP (1)	AP1994A (de)
AR (1)	AR048948A1 (de)
AT (1)	ATE373488T1 (de)
AU (1)	AU2004319259A1 (de)
BR (1)	BRPI0418770A (de)
CA (1)	CA2566440C (de)
CR (1)	CR8748A (de)
DE (1)	DE602004009113T2 (de)
DK (1)	DK1750765T3 (de)
DO (1)	DOP2005000085A (de)
EA (1)	EA009694B1 (de)
EC (1)	ECSP066965A (de)
ES (1)	ES2294577T3 (de)
GE (1)	GEP20094805B (de)
HN (1)	HN2005000210A (de)
HR (1)	HRP20070574T3 (de)
IL (1)	IL178858A (de)
IS (1)	IS8559A (de)
JO (1)	JO2471B1 (de)
MA (1)	MA28603B1 (de)
MX (1)	MXPA06012984A (de)
MY (1)	MY139187A (de)
NI (1)	NI200600270A (de)
NO (1)	NO20065725L (de)
NZ (1)	NZ550892A (de)
PA (1)	PA8633001A1 (de)
PE (1)	PE20060353A1 (de)
PL (1)	PL1750765T3 (de)
PT (1)	PT1750765E (de)
RS (1)	RS20060624A (de)
SA (1)	SA05260130B1 (de)
SI (1)	SI1750765T1 (de)
SM (1)	SM200500011B (de)
SV (1)	SV2006002109A (de)
TN (1)	TNSN06349A1 (de)
UA (1)	UA82782C2 (de)
UY (1)	UY28893A1 (de)
WO (1)	WO2005107809A2 (de)
ZA (1)	ZA200608843B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20090118509A1 (en) *	2005-04-11	2009-05-07	Lupin Limited	Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) *	2008-10-02	2013-11-13	公益財団法人微生物化学研究会	抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) *	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
AU2010292148A1 (en) *	2009-09-11	2012-04-12	Vertex Pharmaceuticals Incorporated	Compositions of N-benzyl-3-(4-chlorophenyl)-2- [methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-N- [3-(4-pyridyl)-1-[2-[4-pyridyl)ethy]propyl]propanamide and uses thereof
HUP1000033A2 (en) *	2010-01-21	2011-07-28	Uratim Kft	Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) *	2021-10-20	2022-11-03	순천향대학교 산학협력단	신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
WO2023217239A1 (zh) *	2022-05-12	2023-11-16	广州嘉越医药科技有限公司	一种药物组合及其应用
US11977085B1 (en)	2023-09-05	2024-05-07	Elan Ehrlich	Date rape drug detection device and method of using same
CN118743705B (zh) *	2024-08-12	2024-11-15	深圳大学	药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5227383A (en) *	1991-06-14	1993-07-13	The University Of Mississippi	Compounds and compositions useful as antifungal and antimycobacterial agents
BR0215873A (pt) *	2002-09-20	2005-07-12	Lupin Ltd	Composto, composição farmacêutica, método de inibição de desenvolvimento de células microbianas, método para o tratamento de condições microbianas em mamìferos e processo para a preparação de um composto

2004
- 2004-05-12 US US10/844,992 patent/US7491721B2/en not_active Expired - Fee Related
- 2004-08-27 NZ NZ550892A patent/NZ550892A/en unknown
- 2004-08-27 CA CA002566440A patent/CA2566440C/en not_active Expired - Fee Related
- 2004-08-27 EA EA200601952A patent/EA009694B1/ru not_active IP Right Cessation
- 2004-08-27 AU AU2004319259A patent/AU2004319259A1/en not_active Abandoned
- 2004-08-27 BR BRPI0418770-9A patent/BRPI0418770A/pt not_active IP Right Cessation
- 2004-08-27 RS YUP-2006/0624A patent/RS20060624A/sr unknown
- 2004-08-27 PT PT04816650T patent/PT1750765E/pt unknown
- 2004-08-27 CN CN2004800431312A patent/CN1956732B/zh not_active Expired - Fee Related
- 2004-08-27 DE DE602004009113T patent/DE602004009113T2/de not_active Expired - Lifetime
- 2004-08-27 UA UAA200612258A patent/UA82782C2/uk unknown
- 2004-08-27 HR HR20070574T patent/HRP20070574T3/xx unknown
- 2004-08-27 SI SI200430552T patent/SI1750765T1/sl unknown
- 2004-08-27 EP EP04816650A patent/EP1750765B1/de not_active Expired - Lifetime
- 2004-08-27 PL PL04816650T patent/PL1750765T3/pl unknown
- 2004-08-27 DK DK04816650T patent/DK1750765T3/da active
- 2004-08-27 JP JP2007512723A patent/JP2007537242A/ja active Pending
- 2004-08-27 ES ES04816650T patent/ES2294577T3/es not_active Expired - Lifetime
- 2004-08-27 AT AT04816650T patent/ATE373488T1/de active
- 2004-08-27 WO PCT/IN2004/000266 patent/WO2005107809A2/en not_active Ceased
- 2004-08-27 AP AP2006003807A patent/AP1994A/xx active
- 2004-08-27 GE GEAP20049749A patent/GEP20094805B/en unknown
- 2004-08-27 MX MXPA06012984A patent/MXPA06012984A/es active IP Right Grant
- 2004-08-27 KR KR1020067023513A patent/KR100854309B1/ko not_active Expired - Fee Related
2005
- 2005-05-11 SV SV2005002109A patent/SV2006002109A/es not_active Application Discontinuation
- 2005-05-11 PE PE2005000526A patent/PE20060353A1/es not_active Application Discontinuation
- 2005-05-11 MY MYPI20052107A patent/MY139187A/en unknown
- 2005-05-11 UY UY28893A patent/UY28893A1/es unknown
- 2005-05-11 AR ARP050101898A patent/AR048948A1/es not_active Application Discontinuation
- 2005-05-11 DO DO2005000085A patent/DOP2005000085A/es unknown
- 2005-05-12 SM SM200500011A patent/SM200500011B/it unknown
- 2005-05-12 HN HN2005000210A patent/HN2005000210A/es unknown
- 2005-05-12 PA PA20058633001A patent/PA8633001A1/es unknown
- 2005-05-12 JO JO200559A patent/JO2471B1/en active
- 2005-05-14 SA SA5260130A patent/SA05260130B1/ar unknown
2006
- 2006-10-24 ZA ZA200608843A patent/ZA200608843B/xx unknown
- 2006-10-25 IL IL178858A patent/IL178858A/en not_active IP Right Cessation
- 2006-10-26 IS IS8559A patent/IS8559A/is unknown
- 2006-10-30 TN TNP2006000349A patent/TNSN06349A1/en unknown
- 2006-10-30 EC EC2006006965A patent/ECSP066965A/es unknown
- 2006-11-10 CR CR8748A patent/CR8748A/es not_active Application Discontinuation
- 2006-11-10 NI NI200600270A patent/NI200600270A/es unknown
- 2006-11-23 MA MA29484A patent/MA28603B1/fr unknown
- 2006-12-12 NO NO20065725A patent/NO20065725L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SI1750765T1 (sl)	2008-04-30
AU2004319259A1 (en)	2005-11-17
ZA200608843B (en)	2008-07-30
US7491721B2 (en)	2009-02-17
CR8748A (es)	2008-06-02
PT1750765E (pt)	2007-12-31
CN1956732B (zh)	2010-04-28
MA28603B1 (fr)	2007-05-02
MXPA06012984A (es)	2007-04-23
SV2006002109A (es)	2006-04-18
DOP2005000085A (es)	2007-01-15
AR048948A1 (es)	2006-06-14
HK1098962A1 (en)	2007-08-03
KR20070007920A (ko)	2007-01-16
DK1750765T3 (da)	2008-01-28
CA2566440A1 (en)	2005-11-17
WO2005107809A3 (en)	2006-01-26
RS20060624A (sr)	2008-09-29
NI200600270A (es)	2007-12-11
ATE373488T1 (de)	2007-10-15
UY28893A1 (es)	2005-12-30
AP1994A (en)	2009-04-09
BRPI0418770A (pt)	2007-10-09
SM200500011A (it)	2005-11-16
KR100854309B1 (ko)	2008-08-26
TNSN06349A1 (en)	2008-02-22
MY139187A (en)	2009-08-28
US20050256128A1 (en)	2005-11-17
IL178858A (en)	2010-06-16
IS8559A (is)	2006-10-26
SM200500011B (it)	2005-11-16
SA05260130B1 (ar)	2008-05-04
JO2471B1 (en)	2009-01-20
JP2007537242A (ja)	2007-12-20
DE602004009113T2 (de)	2008-06-19
ECSP066965A (es)	2006-12-20
GEP20094805B (en)	2009-10-26
EP1750765B1 (de)	2007-09-19
HRP20070574T3 (en)	2008-01-31
IL178858A0 (en)	2007-03-08
NZ550892A (en)	2009-12-24
AP2006003807A0 (en)	2006-12-31
ES2294577T3 (es)	2008-04-01
WO2005107809A2 (en)	2005-11-17
EP1750765A2 (de)	2007-02-14
PE20060353A1 (es)	2006-07-08
CN1956732A (zh)	2007-05-02
HN2005000210A (es)	2009-03-17
PL1750765T3 (pl)	2008-02-29
UA82782C2 (uk)	2008-05-12
DE602004009113D1 (de)	2007-10-31
CA2566440C (en)	2009-08-04
EA200601952A1 (ru)	2007-02-27
WO2005107809A8 (en)	2006-05-18
EA009694B1 (ru)	2008-02-28
PA8633001A1 (es)	2006-12-07

Legal Events

Date	Code	Title	Description
2011-04-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
IL165264A (en)	2011-07-31	Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
NO20080164L (no)	2008-03-14	N-(pyridin-2-yl)-sulfonamidderivater
NO20073405L (no)	2007-07-02	Farmasoytisk utforming inneholdende en frigjoringshastighetskontrollerende sammensetning
NO20042161L (no)	2004-08-17	Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
GEP20125456B (en)	2012-03-26	Azetidines as mek inhibitors for the treatment of proliferative diseases
NO20044866L (no)	2004-12-17	Pyrazolo-pyrimidin-anilin-forbindelser anvendelige som kinase-inhibitorer
GEP20084357B (en)	2008-04-29	Pyrimidine derivatives for the treatment of abnormal cell growth
NO20065904L (no)	2007-02-20	Terapeutiske forbindelser
SE0402762D0 (sv)	2004-11-11	Indazole sulphonamide derivatives
SG164283A1 (en)	2010-09-29	New benzimidazole derivatives
NO20060147L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20060146L (no)	2006-03-07	Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO20051892L (no)	2005-06-17	Ny forbindelse
NO20044549L (no)	2005-01-25	Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
NO20070157L (no)	2007-01-23	Substituerte diketopiperaziner som oksytocinantagonister
NO20051893L (no)	2005-06-17	Ny forbindelse
TNSN06349A1 (en)	2008-02-22	An antimycobacterial pharmaceutical composition
WO2004041802A8 (en)	2005-03-10	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
NO20062491L (no)	2006-09-06	Benzoksazinderivter og deres anvendelse
NO20014855L (no)	2001-12-06	N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
NO20044550L (no)	2005-01-28	Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
NO20065030L (no)	2006-11-30	Aerosolformulering for inhalering av beta agonister.
NO20065873L (no)	2007-02-20	3-(4-(2-dihydroisoksazol-3-ylpyridin-5-yl)fenyl)-5-triazol-1-ylmetyloksoazolidin-2-on derivater som MAO inhibitorer i behandlingen av bakterielle infeksjoner
DE69900961D1 (de)	2002-04-11	Indane-1-ol Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
IL181666A0 (en)	2007-07-04	Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof